Why This Biotech ETF May Be About to Break Out

There’s a chance shares of the iShares Biotechnology ETF IBB may be about to break out. They are testing a resistance level. If they can get above it, a new uptrend may form.

Resistance is a large group of investors looking to sell their shares at, or close to, the same price. As you can see on the following chart, for IBB there has been resistance around $119.

If the shares can trade and hold above it, it will show that the investors who created the resistance are gone. They have cancelled or finished their orders.

With this large amount of supply off the market, traders will be forced to pay higher prices to acquire shares. This could force IBB into a new uptrend.

To learn more about trading, check out the new Benzinga Trading School.

ibb_0.png

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: DividendsTrading Ideas
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!